查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2019978

2026-2034年全球寵物疼痛管理藥物市場規模、佔有率、趨勢和成長分析報告

Global Pet Pain Management Drugs Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計寵物止痛藥物市場規模將從 2025 年的 29.3 億美元成長到 2034 年的 52.7 億美元，2026 年至 2034 年的複合年成長率為 6.72%。

受寵物飼養量增加和人們動物健康意識提高的推動，全球寵物疼痛管理藥物市場正顯著成長。寵物飼主越來越傾向於尋求先進的獸醫護理來保障寵物的健康。寵物慢性疾病（例如關節炎和術後疼痛）的日益普遍，也推動了對有效疼痛管理藥物的需求。此外，寵物「擬人化」以及人們在獸醫護理方面投入的意願增強，也促進了市場成長。

獸醫學的進步進一步推動了市場擴張。包括非類固醇消炎劑（NSAIDs）和生物製劑在內的新藥配方正在改善治療效果。獸醫醫院和診所的擴建也提高了獲得先進疼痛管理方案的機會。此外，動物保健領域研發活動的活性化也促使創新治療方法的問世。

未來幾年，隨著寵物數量的持續成長，寵物止痛藥物市場預計將穩定成長。人們對動物福利的日益關注以及獸醫學的進步將進一步推動止痛治療的普及。此外，更安全、更有效的藥物的研發也將支撐市場的長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球寵物疼痛管理市場：按類型分類

  • 市場分析、洞察與預測
  • NSAIDs
  • 鴉片類藥物
  • 麻醉劑
  • α-2促效劑
  • 其他類型

第5章：全球寵物疼痛管理市場：依給藥途徑分類

  • 市場分析、洞察與預測
  • 口服
  • 腸外
  • 外用

第6章：全球寵物疼痛管理市場：依應用領域分類

  • 市場分析、洞察與預測
  • 關節疼痛
  • 癌症疼痛
  • 術後疼痛
  • 其他用途

第7章：全球寵物疼痛管理藥物市場：依通路分類

  • 市場分析、洞察與預測
  • 獸藥
  • 零售藥房
  • 網路藥房

第8章：全球寵物疼痛管理市場：依動物類型分類

  • 市場分析、洞察與預測
  • 伴侶動物（狗、貓、馬等）
  • 牲畜（牛、豬等）

第9章 全球寵物疼痛管理市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Alivira Animal Health
    • Boehringer Ingelheim
    • Ceva Sante Animale
    • Chanelle Pharma
    • Dechra Pharmaceuticals
    • Elanco Animal Health
    • K-Laser USA
    • Merck
    • Multi Radiance Medical
    • Norbrook
    • Vetoquinol
    • Zoetis
簡介目錄
Product Code: VMR112111026

The Pet Pain Management Drugs Market size is expected to reach USD 5.27 Billion in 2034 from USD 2.93 Billion (2025) growing at a CAGR of 6.72% during 2026-2034.

The global pet pain management drugs market is growing significantly due to increasing pet ownership and rising awareness about animal health. Pet owners are increasingly seeking advanced veterinary treatments to ensure the well-being of their animals. The growing prevalence of chronic conditions such as arthritis and post-surgical pain in pets is driving demand for effective pain management drugs. Additionally, the humanization of pets and willingness to spend on veterinary care are supporting market growth.

Advancements in veterinary pharmaceuticals are further contributing to market expansion. New drug formulations, including non-steroidal anti-inflammatory drugs (NSAIDs) and biologics, are improving treatment outcomes. The expansion of veterinary clinics and hospitals is also increasing access to advanced pain management solutions. Furthermore, increasing research and development activities in animal healthcare are leading to the introduction of innovative therapies.

In the coming years, the pet pain management drugs market is expected to grow steadily as pet ownership continues to rise. The increasing focus on animal welfare and advancements in veterinary medicine will drive further adoption of pain management treatments. Additionally, the development of safer and more effective drugs will support long-term market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • NSAIDs
  • Opioids
  • Anesthetics
  • Alpha-2 agonists
  • Other Types

By Route of Administration

  • Oral
  • Parenteral
  • Topical

By Application

  • Joint Pain
  • Cancer Pain
  • Postoperative Pain
  • Other Applications

By Distribution Channel

  • Veterinary Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Animal Type

  • Companion animals (Dogs, Cats, Horses, Others)
  • Livestock animals (Cattle, Swine, Others)

COMPANIES PROFILED

  • Alivira Animal Health, Boehringer Ingelheim, Ceva Sant Animale, Chanelle Pharma, Dechra Pharmaceuticals, Elanco Animal Health, KLaser USA, Merck, Multi Radiance Medical, Norbrook, Vetoquinol, Zoetis
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PET PAIN MANAGEMENT DRUGS MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. NSAIDs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Opioids Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Anesthetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Alpha-2 agonists Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Other Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PET PAIN MANAGEMENT DRUGS MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Route Of Administration
  • 5.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Parenteral Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PET PAIN MANAGEMENT DRUGS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Joint Pain Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Cancer Pain Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Postoperative Pain Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PET PAIN MANAGEMENT DRUGS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Distribution Channel
  • 7.2. Veterinary Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PET PAIN MANAGEMENT DRUGS MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast Animal Type
  • 8.2. Companion animals (Dogs, Cats, Horses, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Livestock animals (Cattle, Swine, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL PET PAIN MANAGEMENT DRUGS MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Type
    • 9.2.2 By Route Of Administration
    • 9.2.3 By Application
    • 9.2.4 By Distribution Channel
    • 9.2.5 By Animal Type
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Type
    • 9.3.2 By Route Of Administration
    • 9.3.3 By Application
    • 9.3.4 By Distribution Channel
    • 9.3.5 By Animal Type
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Type
    • 9.4.2 By Route Of Administration
    • 9.4.3 By Application
    • 9.4.4 By Distribution Channel
    • 9.4.5 By Animal Type
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Type
    • 9.5.2 By Route Of Administration
    • 9.5.3 By Application
    • 9.5.4 By Distribution Channel
    • 9.5.5 By Animal Type
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Type
    • 9.6.2 By Route Of Administration
    • 9.6.3 By Application
    • 9.6.4 By Distribution Channel
    • 9.6.5 By Animal Type
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL PET PAIN MANAGEMENT DRUGS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Alivira Animal Health
    • 11.2.2 Boehringer Ingelheim
    • 11.2.3 Ceva Sante Animale
    • 11.2.4 Chanelle Pharma
    • 11.2.5 Dechra Pharmaceuticals
    • 11.2.6 Elanco Animal Health
    • 11.2.7 K-Laser USA
    • 11.2.8 Merck
    • 11.2.9 Multi Radiance Medical
    • 11.2.10 Norbrook
    • 11.2.11 Vetoquinol
    • 11.2.12 Zoetis